Clinical and Laboratory Patterns of Pediatric Gross Hematuria

NCT ID: NCT06504771

Last Updated: 2024-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-01

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study the demographic, clinical, laboratory and etiological profile of children with gross hematuria and trace the outcome of these patients for at least 3 months follow up.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Gross hematuria is a scary but common medical problem in children. This condition is considered one of the most important manifestations of kidney and urinary tract diseases. When colour of urine with blood is reddish, brown or dark or cola coloured, the condition is called as macroscopic (gross) hematuria. However, blood in urine may not always be visible to the naked eye, when it is called as microscopic hematuria.

This condition can be transient, intermittent or persistent and it may be symptomatic or asymptomatic. Hematuria originating from glomerulus is almost never bright red but usually brown, tea coloured or cola coloured. In contrary, hematuria originating from the lower urinary tract is usually pink or red in colour.

Pigments and other compounds in certain foods (including beets, berries, and food colourings) and drugs (sulfonamides, rifampicin, ibuprofen, salicylates, phenothiazines, metronidazole, phenolphthalein, chloroquine, deferoxamine, etc.) can change the colour of urine that is called false hematuria.

The causes of hematuria are very diverse, ranging from simple urinary tract infections with rapid recovery to mechanical trauma and severe glomerulonephritis with rapid decline in kidney function, it is essential to recognize the underlying disease and treat it accordingly.

The causes of gross hematuria may be categorized to whether the hematuria is glomerular or non-glomerular in origin. This distinction can be determined by microscopic examination of the urine to detect dysmorphic or monomorphic red blood cells in glomerular and non-glomerular hematuria, respectively. Although glomerular diseases are nearly always associated with some degree of hematuria, gross hematuria as a presenting manifestation is more commonly encountered with acute poststreptococcal glomerulonephritis, lupus nephritis and IgA nephropathy. Non-glomerular hematuria is most often associated with renal stones, tumours, idiopathic hypercalciuria, bacterial or viral urinary tract infection, urolithiasis and structural anomalies of the urinary tract.

It is essential to establish the cause and origin of hematuria in each case through proper history, clinical features and investigations including laboratory, radiological studies and/or percutaneous renal biopsy in some cases. But at the same time, it is important that the pediatrician is aware what any of such procedures might be helpful in establishing a proper diagnosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematuria

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* lnvestigators will include all patients complaining of gross hematuria between the ages of 1 month up to 16 years.

Exclusion Criteria

* Children with external perineal or genital region bleeding which may falsely cause presence of blood in urine samples.
* Patients whose legal guardians will refuse participation in the study.
* Patients with follow up for less than 3 months.
Minimum Eligible Age

1 Month

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Haya Mahmoud Abdelhameed

Pediatric resident at sohag general hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Abdelrahim Sadek, Professor

Role: STUDY_DIRECTOR

Faculty of Medicine, Sohag university, Egypt

Ghada A Abd-Elrehim, Lecturer

Role: STUDY_DIRECTOR

Faculty of Medicine, Sohag university, Egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Medicine,Sohag University

Sohag, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Haya M AbdelHameed, Resident

Role: CONTACT

01065860928

Rania G Mostafa, Lecturer

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

haya M AbdelHameed, Master

Role: primary

01065860928

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-24-06-13MS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.